The introduction of the World Health Organization's multidrug therapy (WHO‐MDT) has significantly advanced leprosy treatment. Although dapsone is a fundamental component of MDT, it presents risks of adverse drug reactions… Click to show full abstract
The introduction of the World Health Organization's multidrug therapy (WHO‐MDT) has significantly advanced leprosy treatment. Although dapsone is a fundamental component of MDT, it presents risks of adverse drug reactions (ADR), including the potentially fatal dapsone hypersensitivity syndrome (DHS).
Keywords:
dapsone;
multidrug therapy;
dapsone hypersensitivity;
hypersensitivity syndrome
Journal Title: International Journal of Dermatology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: International Journal of Dermatology
Year Published: 2025
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!